
Sign in to view content
FIDO Study: 10-Year Outcomes of Eyes Receiving Continuous, Fixed-Interval Dosing of Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
- Video
- Published 2019
Ivan J. Suner, MD, MBA
AMD Neovascular Part II Symposium
Related
Category: AMD-Neovascular